Inhibitor Therapeutics (INTI) Enterprise Value (2013 - 2026)
Inhibitor Therapeutics' Enterprise Value was $13.39 million in Q2 2026, up 323.0% from $3.17 million a year earlier but down 24.3% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Enterprise Value (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Inhibitor Therapeutics' Enterprise Value was $6.72 million through Jun 30, 2026; for FY2025, it came in at $6.25 million, up 32.1% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of -15.9% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $4.73 million in FY2024 (-28.8%), $6.64 million in FY2023 (-73.1%), $24.67 million in FY2022 (-56.3%) and $56.5 million in FY2021 (+279.9%).
- Quarterly Enterprise Value has moved between -$3.22 million (Q2 2023) and $56.5 million (Q4 2021) over five years.
- Compared with a year earlier, Enterprise Value has increased for three straight quarters, with growth averaging 78.0% over the last seven quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2026 (growth of 323.0%); the worst was Q4 2023 (a decline of 73.1%).
- Per Business Quant data, INTI's Enterprise Value in the three quarters before Q2 2026 was $17.69 million (Q1 2026), $6.25 million (Q4 2025) and $5.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.39 Mn |
| Mar 31, 2026 | 17.69 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | 5.63 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 4.29 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 9.11 Mn |
| Jun 30, 2024 | 6.69 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | -936,440.62 |
| Jun 30, 2023 | -3.22 Mn |
| Mar 31, 2023 | -475,353.19 |
| Dec 31, 2022 | 24.67 Mn |
| Sep 30, 2022 | 18.79 Mn |
| Jun 30, 2022 | 37.66 Mn |
| Mar 31, 2022 | 48.96 Mn |
| Dec 31, 2021 | 56.50 Mn |
| Sep 30, 2021 | 56.28 Mn |
API Access
Inhibitor Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();